celecoxib has been researched along with Hepatitis, Autoimmune in 1 studies
Hepatitis, Autoimmune: A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Concanavalin A (ConA) is an established model for inducing autoimmune hepatitis (AIH) in mice, mimicking clinical features in human." | 1.91 | Celecoxib abrogates concanavalin A-induced hepatitis in mice: Possible involvement of Nrf2/HO-1, JNK signaling pathways and COX-2 expression. ( El-Sheakh, AR; Khaleel, A; Suddek, GM, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khaleel, A | 1 |
| El-Sheakh, AR | 1 |
| Suddek, GM | 1 |
1 other study available for celecoxib and Hepatitis, Autoimmune
| Article | Year |
|---|---|
Celecoxib abrogates concanavalin A-induced hepatitis in mice: Possible involvement of Nrf2/HO-1, JNK signaling pathways and COX-2 expression.
Topics: Animals; Antioxidants; Beclin-1; Caspase 3; Celecoxib; Concanavalin A; Cyclooxygenase 2; Heme Oxygen | 2023 |